The obligate intracellular bacterium Chlamydia pneumoniae has recently been implicated in
the pathogenesis of atherosclerosis. Serological response to Chlamydia pneumoniae …

Abstract Objective: The role of Chlamydia pneumoniae in atherosclerosis is still debated. In
this study a novel mouse model was applied to determine the direct impact of C …

Objective: To assess the role of oral rapamycin in the prevention of coronary restenosis in
patients undergoing coronary stenting. Methods: From December 2001 through February …

Chlarnydia pneumoniae is now a well-established cause of community-acquired respiratory
disease in children and adults [1, 2]. Recent evidence has also suggested that this organism …

At the congress of the European Society of Cardiology in Amsterdam in 2000, I (PWS) was
asked to give the Andreas Gruentzig Lecture. In the week preceding the lecture, we re …

BACKGROUND: Previous studies have shown an incremental role of inflammation in late
prognosis following coronary stenting (CS). In particular, high preprocedural levels of …

LE Nicolle MD FRCP, Editor-in-Chief us to cling to an antimicrobial approach to
management? Some of this is explained by the 'usual suspects'. The research community …

Objectives: To evaluate whether antimicrobial chemotherapy prevents acceleration of
atherosclerotic lesion development induced by infection with Chlamydia pneumoniae …

Background The various factors that initiate coronary atherosclerosis and calcification are
unclear. Chlamydia pneumoniae has been implicated in several diseases, including …

Objective: Rapamycin-coated stents in coronary artery lesions have recently been shown to
be effective in inhibiting neointimal formation. However, little is known about the effects of …